On 13 June 2008, the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) published on its website a 110-page long document that it has submitted to the European Commission, as a response to the latter’s ongoing pharmaceutical sector inquiry. In contrast to claims made by the Commission when it launched the sector inquiry earlier this year, EFPIA argues in its submission that there is no clear evidence of a marked decline in innovation by the European pharmaceutical industry. Instead, EFPIA argues that the
Share on
|
|
The EU Commission receives a document submitted by the European pharmaceutical industry (EFPIA)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
